Selenium and alzheimer's disease: A systematic review

Journal of Alzheimer's Disease

Volumn 26, Issue 1, 2011, Pages 81-104

  Loef, Martin ^a,d   Schrauzer, Gerhard N ^b,c   Walach, Harald ^a,d  

^a EUROPEAN UNIVERSITY VIADRINA   (Germany)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c Biological Trace Element Research Institute   (United States)

^d European Office   (Germany)

Author keywords

Alzheimer's disease; amyloid ; dementia; NF B; oxidative stress; selenium; selenoproteins; systematic review trace elements; tau

Indexed keywords

ALPHA TOCOPHEROL; AMYLOID BETA PROTEIN; CELL MEMBRANE PROTEIN; COLOSTRININ; GLUTATHIONE PEROXIDASE; HOMOCYSTEINE; METHIONINE SULFOXIDE REDUCTASE B; PLACEBO; POLYUNSATURATED FATTY ACID; PROLINE RICH PROTEIN; SELENIUM; SELENIUM DERIVATIVE; SELENOMETHIONINE; SELENOPROTEIN M; SODIUM SELENITE; STREPTOCYTOCIN; TAU PROTEIN; THIOREDOXIN REDUCTASE; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; AUTOPSY; BLOOD LEVEL; BRAIN LEVEL; CEREBROSPINAL FLUID LEVEL; COGNITION; DIET SUPPLEMENTATION; DRUG POTENTIATION; HUMAN; MERCURIALISM; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; SYSTEMATIC REVIEW; TELOMERE;

EID: 80052837908     PISSN: 13872877     EISSN: 18758908     Source Type: Journal    
DOI: 10.3233/JAD-2011-110414     Document Type: Review

References (299)

1. Rayman MP (2000) The importance of selenium to human health. The Lancet 356, 233-241. (Pubitemid 30446984)
2. Reeves MA, Hoffmann PR (2009) The human selenopro-teome: recent insights into functions and regulation. Cell Mol Life Sci 66, 2457-2478.
3. Bellinger FP, Raman AV, Reeves MA, Berry MJ (2009) Regulation and function of selenoproteins in human disease. Biochem J 422, 11-22.
4. Papp LV, Lu J, Holmgren A, Khanna KK (2007) From selenium to selenoproteins: synthesis, identity, and their role in human health. Antioxid Redox Signal 9, 775-806. (Pubitemid 46919583)
5. Alzheimer's disease international, World Alzheimer Report, http://www.alz.co.uk/research/files/WorldAlzheimerReport. pdf, Accessed September 01, 2010.
6. Hebert LE, Scherr PA, Bienias JL, Bennett DA, Evans DA (2003) Alzheimer disease in the US population: prevalence estimates using the 2000 census. Arch Neurol 60, 1119-1122. (Pubitemid 36975801)
7. U.S. Census Bureau, National Population Projections-Summary Tables 1998-2000, http://www.census.gov/pop ulation/www/projections/natsum-T3.html, Accessed September 02, 2010.
8. Selkoe DJ (2001) Alzheimer's disease: genes, proteins, and therapy. Physiol Rev 81, 741-766. (Pubitemid 32267077)
9. Hardy J, Selkoe DJ (2002) The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science 297, 353-356. (Pubitemid 34790756)
10. Markesbery WR, Carney JM (1999) Oxidative alterations in Alzheimer's disease. Brain Pathol 9, 133-146. (Pubitemid 29056524)
11. Markesbery WR (1997) Oxidative stress hypothesis in Alzheimer's disease. Free Radic Biol Med 23, 134-147. (Pubitemid 27217017)
12. Ballatore C, Virginia VM, Trojanowski JK (2007) Tau-mediated neurodegeneration in Alzheimer's disease and related disorders. Nat Rev Neurosci 8, 663-672. (Pubitemid 47283144)
13. Braak H, Braak E (1991) Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol 82, 239-259.
14. Wenk GL (2003) Neuropathologic changes in Alzheimer's disease. J Clin Psychiatr 64 Suppl 9, 7-10. (Pubitemid 37040372)
15. Zhang C, Caroline Rocourt, Cheng WH (2010) Selenopro-teins and the aging brain. Mech Ageing Dev 131, 253-260.
16. Berr C, Akbaraly T, Arnaud J, Hininger I, Roussel AM, Bar-berger Gateau P (2009) Increased selenium intake in elderly high fish consumers may account for health benefits previously ascribed to omega-3 fatty acids. J Nutr Health Aging 13, 14-18.
17. Schwarz K, Foltz CM (1958) Factor 3 activity of selenium compounds. J Biol Chem 233, 245-251.
18. Trelease SF, Beath OA (1949) Selenium. Its Geological Occurrence and its Biological Effects in Relation to Botany, Chemistry, Agriculture, Nutrition and Medicine. Published by the Authors, New York.
19. National Academy of Sciences. Institute of Medicine (2000), Dietary Reference Intakes: Vitamin C, Vitamin E, Selenium and Carotenoids, National Academy Press, Washington DC.
20. Thomson CD (2004) Assessment of requirements for selenium and adequacy of selenium status: a review. Eur J Clin Nutr 58, 391-402. (Pubitemid 38443698)
21. Combs GF Jr (2007) Selenium in global food systems. Br J Nutr 85, 517-547.
22. Berr C, Nicole A, Godin J, Ceballos-Picot I, Thevenin M, Dartigues JF, Alperovitch A (1993) Selenium and oxygen-metabolizing enzymes in elderly community residents: a pilot epidemiological study. J Am Geriatr Soc 41, 143-148. (Pubitemid 23051422)
23. Savarino L, Granchi D, Ciapetti G, Cenni E, Ravaglia G, Forti P, Maioli F, Mattioli R (2001) Serum concentrations of zinc and selenium in elderly people: results in healthy nonagenarians/centenarians. Exp Gerontol 36, 327-339. (Pubitemid 32164435)
24. Taylor EW, Nadimpalli RG, Ramanathan CS (1997) Genomic structures of viral agents in relation to the biosynthesis of selenoproteins. Biol Trace Elem Res 56, 63-91 (Pubitemid 27198251)
25. United States Department of Agriculture (2010) National Nutrient Database for Standard Reference, Release 22, http://fnic.nal.usda.gov/nal display/index.php?tax level =1&info center=4&tax subject=279, Accessed September 07, 2010.
26. Ip C (1998) Lessons from basic research in selenium and cancer prevention. J Nutr 128, 1845-1854. (Pubitemid 28509845)
27. Krol A (2002) Evolutionarily different RNA motifs and RNA-protein complexes to achieve selenoprotein synthesis. Biochimie 84, 765-774. (Pubitemid 35363461)
28. Kryukov GV, Castellano SV, Novoselov S, Lobanov AV, Zehtab O, Guigo R, Gladyshev VN (2003) Characterization of mammalian selenoproteomes. Science 300, 1439-1443. (Pubitemid 36638165)
29. Hill KE, Lloyd RS, Yang JG, Read R, Burk RF (1991) The cDNA for rat selenoprotein P contains 10 TGA codons in the open reading frame. J Biol Chem 266, 10050-10053.
30. Hill KE, Zhou J, McMahan WJ, Motley AK, Atkins JF, Gesteland RF, Burk RF (2003) Deletion of selenoprotein P alters distribution of selenium in the mouse. J Biol Chem 278, 13640-13646. (Pubitemid 36799899)
31. Schomburg L, Schweizer U, Holtmann B, Flohé L, Sendtner M, Köhrle J (2003) Gene disruption discloses role of seleno-protein P in selenium delivery to target tissues. Biochem J 370, 397-402. (Pubitemid 36315127)
32. Saito Y, Hayashi T, Tanaka A, Watanabe Y, Suzuki M, Saito E, Takahashi K (1999) Selenoprotein P in human plasma as an extracellular phospholipid hydroperoxide glu-tathione peroxidase. J Biol Chem 274, 2866-2871.
33. Mills GC (1957) Hemoglobin catabolism. I. Glu-tathione peroxidase, an erythrocyte enzyme which protects hemoglobin from oxidative breakdown. J Biol Chem 229, 189-197.
34. Flohe L, Günzler WA, Schock HH (1973) Glutathione per-oxidase: a selenoenzyme. FEBS Lett 32, 132-134.
35. Takahashi K, Avissar N, Whitin J, Cohen H (1987) Purification and characterization of human plasma glu-tathione peroxidase: a selenoglycoprotein distinct from the known cellular enzyme. Arch Biochem Biophys 256, 677-686. (Pubitemid 17121963)
36. Conrad M, Schneider M, Seiler A, Bornkamm GW (2007) Physiological role of phospholipid hydroperoxide glutathione peroxidase in mammals. Biol Chem 388, 1019-1025. (Pubitemid 47584306)
37. Arthur JR, Beckett GJ (1999) Thyroid function. Br Med Bull 55, 658-668.
38. Arnér ES, Holmgren A (2000) Physiological functions of thioredoxin and thioredoxin reductase. Eur J Biochem 267, 6102-6109.
39. Guimarães MJ, Peterson D, Vicari A, Cocks BG, Copeland NG, Gilbert DJ, Jenkins NA, Ferrick DA, Kastelein RA, Bazan JF, Zlotnik A (1996) Identification of a novel selD homolog from Eukaryotes, Bacteria, and Archaea: Is there an autoregulatory mechanism in selenocysteine metabolism? Proc Natl Acad Sci USA 93, 15086-15091. (Pubitemid 27009556)
40. Papp LV, Lu J, Bolderson E, Boucher D, Singh R, Holm-grenA, Khanna K (2010) SECIS-binding protein2promotes cell survival by protecting against oxidative stress. Antioxid Redox Signal 12, 797-808.
41. Lim WS, Gammack JK, Van Niekerk J, Dangour AD (2006) Omega 3 fatty acid for the prevention of dementia. Cochrane Database Syst Rev 1, CD005379.
42. Ishrat T, Parveen K, Khan MM, Khuwaja G, Khan MB, Yousuf S, Ahmad A, Shrivastav P, Islam F (2009) Selenium prevents cognitive decline and oxidative damage in rat model of streptozotocin-induced experimental dementia of Alzheimer's type. Brain Res 1281, 117-127.
43. Ani M, Moshtaghie AA, Aghadavood M (2007) Protective effects of selenium and zinc on the brain acetyl cholinesterase activity in lead intoxified rat. Res Pharm Sci 1, 80-84.
44. Knorpp T, Robinson SR, Crack PJ, Dringen R (2006) Glutathione peroxidase-1 contributes to the protection of glutamine synthetase in astrocytes during oxidative stress. J Neural Transm 113, 1145-1155. (Pubitemid 44291010)
45. Castaño A, Ayala A, Rodŕiguez-Gómez JA, Herrera AJ, Cano J, Machado A (1997) Low selenium diet increases the dopamineturnoverinprefrontal cortexofthe rat.Neurochem Int 30, 549-555. (Pubitemid 27187225)
46. Bartus RT, Dean RL 3 rd, Beer B, Lippa AS (1982) The cholinergic hypothesis of geriatric memory dysfunction. Science 217, 408-414.
47. Palmer AM, Francis PT, Benton JS, Sims NR, Mann DM, Neary D, Snowden JS, Bowen DM (1987) Presynaptic sero-tonergic dysfunction in patients with Alzheimer's disease. J Neurochem 48, 8-15. (Pubitemid 17031359)
48. Bowen DM, Palmer AM, Francis PT, Procter AW, Lowe SL (1988) "Classical" neurotransmitters in Alzheimer disease. In Aging and the Brain, Terry RD, ed. Raven Press, pp. 115-128.
49. Davies P, Katzman R, Terry RD (1980) Reduced somatostatin-like immunoreactivity in cerebral cortex from cases of Alzheimer disease and Alzheimer senile dementia. Nature 288, 279-280. (Pubitemid 11165878)
50. Gao S, Jin Y, Hall KS, Liang C, Unverzagt FW, Ma F, Cheng Y, Shen J, Cao J, Matesan J, Li P, Bian J, Hendrie HC, Murrell JR (2009) Selenium level is associated with apoE 4 in rural elderly Chinese. Public Health Nutr 12, 2371-2376.
51. Bellinger FP, He QP, Bellinger MT, Lin Y, Raman AV, White LR, Berry MJ (2008) Association of selenoprotein p with Alzheimer's pathology in human cortex. J Alzheimers Dis 15, 465-472.
52. Burk RF, Hill KE, Olson GE, Weeber EJ, Motley AK, Winfrey VP, Austin LM (2007) Deletion of apolipoprotein E receptor-2 in mice lowers brain selenium and causes severe neurological dysfunction and death when a low-selenium diet is fed. J Neurosci 27, 6207-6211. (Pubitemid 46890009)
53. Hwang DY, Cho JS, Oh JH, Shim SB, Jee SW, Lee SH, Seo SJ, Lee SK, Lee SH, Kim YK (2005) Differentially expressed genes in transgenic mice carrying human mutant presenilin-2 (N141I): correlation of selenoprotein M with Alzheimer's disease. Neurochem Res 30, 1009-1019. (Pubitemid 41570036)
54. Farrer LA, Cupples LA, Haines JL, Hyman B, Kukull WA, Mayeux R, Myers RH, Pericak-Vance MA, Risch N, van Duijn CM (1997) Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease: a meta-analysis. JAMA 278, 1349-1356. (Pubitemid 27449696)
55. Bentahir M, Nyabi O, Verhamme J, Tolia A, Horré K, Wiltfang J, Esselmann H, De Strooper B (2006) Presenilin clinical mutations can affect gamma-secretase activity by different mechanisms. J Neurochem 96, 732-742.
56. Wenstrup D, Ehman WD, Markesbery WR (1990) Trace element imbalances in isolated subcellular fractions of Alzheimer's disease brains. Brain Res 533, 125-131. (Pubitemid 20375807)
57. Lacour M, Zunder T, Restle A, Schwarzer G (2004) No evidenceforanimpactofselenium supplementationonenvi-ronment associated health disorders-a systematic review. Int J Hyg Environ Health 207, 1-13. (Pubitemid 38082248)
58. Cornelli U (2010) Treatment of Alzheimer's Disease with a Cholinesterase Inhibitor Combined with Antioxidants. Neu-rodegenerative Dis 7, 193-202.
59. Van Rhijn AG, Prior CA, Corrigan FM (1990) Dietary supplementation with zinc sulphate, sodium selenite and fatty acids in early dementia of Alzheimer's type. J Nutr Med 1, 259-266.
60. Chandra RK (2001) Effectofvitamin and trace-element supplementation on cognitive function in elderly subjects. Nutrition 17, 709-712. (Pubitemid 32821143)
61. ®: a proline-rich polypep-tide (PRP) complex isolated from ovine colostrum for treatment of Alzheimer's disease. A double-blind, placebo-controlled study. Arch Immunol Ther Exp (Warsz) 47, 377-384.
62. Scheltens P, Kamphuis PJ, Verhey FR, Olde Rikkert MG, Wurtman RJ, Wilkinson D, Twisk JW, Kurz A (2010) Effi-cacy of a medical food in mild Alzheimer's disease: a randomized, controlled trial. Alzheimers Dement 6, 1-10.
63. Gariballa S, Forster S (2007) Effects of dietary supplements on depressive symptoms in older patients: a randomised double-blind placebo-controlled trial. Clin Nutr 26, 545-551. (Pubitemid 47618321)
64. Tolonen M, Halme M, Sarna S (1985) Vitamin E and selenium supplementation in geriatric patients. Biol Trace Elem Res 7, 161-168.
65. Berr C, Balansard B, Arnaud J, Roussel AM, Alperovitch A (2000) Cognitive decline is associated with systemic oxida-tive stress: the EVA study. J Am Geriatr Soc 48, 1285-1291.
66. Mendelsohn AB, Belle SH, Stoehr GP, Ganguli M (1998) Use of antioxidant supplements and its association with cognitive functioninarural elderly cohort: the MoVIES project. Am J Epidemiol 148, 38-44. (Pubitemid 28317543)
67. Akbaraly NT, Arnaud J, Hininger-Favier I, Gourlet V, Rous-sel A, Berr C (2005) Selenium and mortality in the elderly: results from the EVA study. Clin Chem 51, 2117-2123. (Pubitemid 41532628)
68. Akbaraly NT, Hininger-Favier I, Carriere I, Arnaud J, Gourlet V, Roussel AN, Berr C (2007) Plasma selenium over time and cognitive decline in the elderly. Epidemiology 18, 52-58. (Pubitemid 46005909)
69. Gray SL, Hanlon JT, Landerman LR, Artz M, Schmader KE, Fillenbaum GG (2003) Is antioxidant use protective of cognitive function in the community-dwelling elderly? Am J Geriatr Pharmacother 1, 3-10. (Pubitemid 40410982)
70. Engelhart MJ, Ruitenberg A, Swieten JC, Witteman JC, Hofman A, Breteler MM (2000) Dietary anti-oxidants and the risk of dementia. The Rotterdam study. Neurobiol Aging 21, 203.
71. Berr C, Richard MJ, Gourlet V, Garrel C, Favier A (2004) Enzymatic antioxidant balance and cognitive decline in aging-the EVA study. Eur J Epidemiol 19, 133-138. (Pubitemid 38374563)
72. Cardoso BR, Ong TP, Jacob-Filho W, Jaluul O, Freitas MI, Cozzolino SM (2010) Nutritional status of selenium in Alzheimer's disease patients. Br J Nutr 103, 803-806.
73. Mart́in-Aragón S, Bermejo-Bescós P, Bened́i J, Felici E, Gil P, Ribera JM, Villar AM (2009) Metalloproteinase's activity and oxidative stress in mild cognitive impairment and Alzheimer's disease. Neurochem Res 34, 373-378.
74. Smorgon C, Mari E, Atti AR, Dalla Nora E, Zamboni PF, Calzoni F, Passaro A, Fellin R (2004) Trace elements and cognitive impairment: an elderly cohort study. Arch Geron-tolGeriatr 9, 393-402. (Pubitemid 38822890)
75. Meseguer I, Molina JA, Jiménez-Jiménez FJ, Aguilar MV, Mateos-Vega CJ, González-Muñoz MJ, de Bustos F, ́́ Orti-Pareja M, Zurdo M, Berbel A, Barrios E, Martinez-Para MC (1999) Cerebrospinalfluid levelsofseleniumin patients with Alzheimer's disease. J Neural Transm 106, 309-315. (Pubitemid 29196934)
76. Cornett CR, Markesbery WR, Ehmann WD (1998) Imbalances of trace elements related to oxidative damage in Alzheimer's disease brain. Neurotoxicology 19, 339-345.
77. Cornett CR, Ehmann WR, Wekstein WD, Markesbery W (1998) Trace elements in Alzheimer's disease pituitary glands. Biol Trace Elem Res 62, 107-114. (Pubitemid 28246538)
78. Samudralwar DL, Diprete CC, Ni BF, Ehmann WD, Markesbery WR (1995) Elemental imbalances in the olfactory pathway in Alzheimer's disease. J Neurol Sci 130, 139-145.
79. Ehmann WD, Markesbery WR, Alauddin M, Hossain TI, Brubaker EH (1986) Brain trace elements in Alzheimer's disease. Neurotoxicology 7, 197-206. (Pubitemid 16116632)
80. Basun H, Forssell LG, Wetterberg L, Winblad B (1991) Metals and trace elements in plasma and cerebrospinal fluid in normal aging and Alzheimer's disease. J Neural Transm Park Dis Dement Sect 3, 231-258.
81. Jeandel C, Nicolas MB, Dubois F, Nabet-Belleville F, Penin F, Cuny G (1989) Lipid peroxidation and free radical scavengers in Alzheimer's disease. Gerontology 35, 275-282. (Pubitemid 20015238)
82. Annerén G, Gardner A, Lundin T (1986) Increased glu-tathione peroxidase activity in erythrocytes in patients with Alzheimer's disease/senile dementia of Alzheimer's type. Acta Neurol Scand 73, 586.
83. Vural H, Demirin H, Kara Y, Eren I, Delibas N (2010) Alter-ationsofplasma magnesium, copper, zinc, ironand selenium concentrations and some related erythrocyte antioxidant enzyme activities in patients with Alzheimer's disease. J Trace Elem Med Biol 24, 169-173.
84. Gerhardsson L, Lundh T, Minthon L, Londos E (2008) Metal concentrations in plasma and cerebrospinal fluid in patients with Alzheimer's disease. Dement Geriatr Cogn Disord 25, 508-515. (Pubitemid 351957413)
85. Panayi AE, Spyrou NM, Ubertalli LC, Akanle OA, Part P (2000) Differences in trace element concentrations between the right and left hemispheres of human brain using INAA. J Radioanal Nucl Chem 244, 205-207. (Pubitemid 30456638)
86. Stedman JD, Spyrou NM (1997) Elemental analysis of the frontal lobe of "normal" brain tissue and that affected by Alzheimer's disease. J Radioanal Nucl Chem 217, 163-166.
87. Ceballos-Picot I, Merad-Boudia M, Nicole A, Thevenin M, Hellier G, Legrain S, Berr C (1996) Peripheral antioxidant enzyme activities and selenium in elderly subjects and in dementia of Alzheimer's type-place of the extracellular glutathione peroxidase. Free Radic Biol Med 20, 579-587. (Pubitemid 26097275)
88. Thompson CM, Markesbery WR, Ehmann WD, Mao YX, Vance DE (1988) Regional brain trace-element studies in Alzheimer's disease. Neurotoxicology 9, 1-8.
89. Rinaldi P, Polidori MC, Metastasio A, Mariani E, Mattioli P, Cherubini A, Catani M, Cecchetti R, Senin U, Mecocci P (2003) Plasma antioxidants are similarly depleted in mild cognitive impairment and in Alzheimer's disease. Neurobiol Aging 24, 915-919. (Pubitemid 36962976)
90. Padurariu M, Ciobica A, Hritcu L, Stoica B, Bild W, Ste-fanescu C (2009) Changes of some oxidative stress markers in the serum of patients with mild cognitive impairment and Alzheimer's disease. Neurosci Lett 469, 6-10.
91. Ansari MA, Scheff SW (2010) Oxidative stress in the progression of Alzheimer disease in the frontal cortex. J Neuropathol Exp Neurol 69, 155-167.
92. Kharrazi H, Vaisi-Raygani A, Rahimi Z, Tavilani H, Aminian M, Pourmotabbed T (2008) Association between enzymatic and non-enzymatic antioxidant defense mechanism with apolipoproteinE genotypes in Alzheimer disease. Clin Biochem 41, 932-936.
93. Tabet N, Mantle D, Walker Z, Orrell M (2001) Vitamins, trace elements, and antioxidant status in dementia disorders. Int Psychogeriatr 13, 265.
94. Ramassamy C, Averill D, Beffert U, Theroux L, Lussier-Cacan S, Cohn JS, Christen Y, Schoofs A, Davignon J, Poirier J (2000) Oxidative insults are associated with apolipoprotein E genotype in Alzheimer's disease brain. Neurobiol Dis 7, 23-37. (Pubitemid 30141817)
95. Marcus DL, Thomas C, Rodriguez C, Simberkoff K, Tsai JS, Strafaci JA, Freedman ML (1998) Increased peroxida-tion and reduced antioxidant enzyme activityin Alzheimer's disease. Exp Neurol 150, 40-44. (Pubitemid 28146421)
96. Hayn M, Kremser K, Singewald N, Cairns N, Nemethova M, Lubec B, Lubec G (1996) Evidence against the involvement of reactive oxygen species in the pathogenesis of neuronal death in Down's syndrome and Alzheimer's disease. Life Sci 59, 537-544. (Pubitemid 26274415)
97. Lovell MA, Ehmann WD, Butler SM, Markesbery WR (1995) Elevated thiobarbituric acid-reactive substances and antioxidant enzyme activity in the brain in Alzheimer's disease. Neurology 45, 1594-1601.
98. Leite RE, Jacob-Filho W, Saiki M, Grinberg LT, Ferretti RE (2008) Determination of trace elements in human brain tissues using neutron activation analysis. J Radioanal Nucl Chem 278, 581-584.
99. Schuessel K, Leutner S, Cairns NJ, Müller WE, Eckert A (2004) Impact of gender on upregulation of antioxidant defence mechanisms in Alzheimer's disease brain. J Neural Transm 111, 1167-1182. (Pubitemid 39222776)
100. Lovell MA, Xie C, Gabbita SP, Markesbery WR (2000) Decreased thioredoxin and increased thioredoxin reductase levels in Alzheimer's disease brain. Free Radic Biol Med 28, 418-427. (Pubitemid 30110658)
101. Kish SJ, Morito CL, Hornykiewicz O (1986) Brain glutathione peroxidaseinneurodegenerative disorders. Neu-rochem Pathol 4, 23-28.
102. Paz-y-Miño C, Carrera C, López-Cortés A, Muñoz MJ, Cumbal N, Castro B, Cabrera A, Sánchez ME (2010) Genetic polymorphisms in apolipoprotein E and glutathione peroxidase 1 genes in the Ecuadorian population affected with Alzheimer's disease. Am J Med Sci 340, 373-377.
103. Strozyk D, Launer LJ, Adlard PA, Cherny RA, Tsatsanis A, Volitakis I, Blennow K, Petrovitch H, White LR, Bush AI (2009) Zinc and copper modulate Alzheimer Abeta levels in human cerebrospinal fluid. Neurobiol Aging 30, 1069-1077.
104. Aksenov MY, Tucker HM, Nair P, Aksenova MV, Butterfield DA, Estus S, Markesbery WR (1998) The expression of key oxidative stress-handling genes in different brain regions in Alzheimer's disease. J Mol Neurosci 11, 151-164. (Pubitemid 29140165)
105. Chen L, Richardson JS, Caldwell JC, Ang LC (1994) Regional brain activity of free radical defense enzymes in autopsy samples from patients with Alzheimer's disease and from nondemented controls. Int JNeurosci 75, 83-90. (Pubitemid 2072086)
106. Cutts DA, Maguire RP, Stedman JD, Leenders KL, Spy-rou NM (1999) A comparative study in Alzheimer's and normal brains of trace element distribution using PIXE and INA analyses and glucose metabolism by positron emission tomography. Biol Trace Elem Res 71, 541-549. (Pubitemid 30041488)
107. Tabet N, Mantle D, Walker Z, Orrell M (2005) Higher fat and carbohydrate intake in dementia patients is associated with increased blood glutathione peroxidase activity. Int Psychogeriatr 17, 91-98. (Pubitemid 40593650)
108. Gao S, Jin Y, Hall KS, Liang C, Unverzagt FW, Ji R, Murrell JR, Cao J, Shen J, Ma F, Matesan J, Ying B, Cheng Y, Bian J, Li P, Hendrie HC (2007) Selenium level and cognitive function in rural elderly Chinese. Am J Epidemiol 165, 955-965. (Pubitemid 46536659)
109. Perkins AJ, Hendrie HC, Callahan CM, Gao S, Unverzagt FW, Xu Y, Hall KS, Hui SL (1999) Association of antioxi-dants with memory in amultiethnic elderly sample using the Third National Health and Nutrition Examination Survey. Am J Epidemiol 150, 37-44. (Pubitemid 29297266)
110. Liang C, Ji R, Cao J, Jiang Y, Yu B, Ma F, Wu Y, Ying B, Zhang Y (2003) Relations between trace elements in drinking water and elderly residents' cognitive function. J Hygiene Res 32, 436-440.
111. Emsley CL, Gao S, Li Y, Liang C, Ji R, Hall KS, Cao J, Ma F, Wu Y, Ying P, Zhang Y, Sun S, Unverzagt FW, Slemenda CW, Hendrie HC (2000) Trace element levels in drinking water and cognitive function among elderly Chinese. Am J Epidemiol 151, 913-920. (Pubitemid 30461132)
112. Kaplan E, Bigelow D, Vatassery G, Ansari K (1982) Gluta-thione peroxidase in human cerebrospinal fluid. Brain Res 252, 391-393. (Pubitemid 13238959)
113. Gerhardsson L, Blennow K, Lundh T, Londos E, Minthon L (2009) Concentrations of metals, beta-amyloid and taumarkers in cerebrospinal fluid in patients with Alzheimer's disease. Dement Geriatr Cogn Disord 28, 88-94.
114. Clausen J, Nielsen S, Kristensen M (1989) Biochemical and clinical effects of an antioxidative supplementation of geriatric patients. Biol Trace Elem Res 20, 135-151. (Pubitemid 19120173)
115. Calabrese V, Sultana R, Scapagnini G, Guagliano E, Sapienza M, Bella R, Kanski J, Pennisi G, Mancuso C, Stella AM, Butterfield DA (2006) Nitrosative stress, cellular stress response, and thiol homeostasisin patients with Alzheimer's disease. Antioxid Redox Signal 8, 1975-1986. (Pubitemid 46489625)
116. Ward NI, Mason JA (1987) Neutron activation analysis techniques for identifying elemental status in Alzheimer's disease. J Radioanal Nucl Chem 113, 515-526. (Pubitemid 18053924)
117. Corrigan FM, Reynolds GP, Ward NI (1993) Hippocampal tin, aluminum and zinc in Alzheimer's disease. Bio Metals 6, 149-154.
118. Kryscio RJ, Mendiondo MS, Schmitt FA, Markesbery WR (2004) Designing a large prevention trial: statistical issues. Stat Med 23, 285-296. (Pubitemid 38100641)
119. Wirth EK, Conrad M, Winterer J, Wozny C, Carlson BA, Roth S, Schmitz D, Bornkamm GW, Coppola V, Tessarollo L, Schomburg L, Köhrle J, Hatfield DL, Schweizer U (2010) Neuronal selenoprotein expression is required for interneuron development and prevents seizuresand neurodegeneration. FASEB J 24, 844-852.
120. Yoo MH, Gu X, Xu XM, Kim JY, Carlson BA, Patterson AD, Cai H, Gladyshev VN, Hatfield DL (2010) Delineating the role of glutathione peroxidase 4 in protecting cells against lipid hydroperoxide damage and in Alzheimer's disease. Antioxid Redox Signal 12, 819-827.
121. Yim SY, Chae KR, Shim SB, Hong JT, Park JY, Lee CY, Son HJ, Sheen YY, Hwang DY (2009) ERK activation induced by selenium treatment significantly downregulates beta/gamma-secretase activity and Tau phosphorylation in the transgenic rat overexpressing human selenoprotein M. Int J Mol Med 24, 91-96.
122. Lovell MA, Xiong S, Lyubartseva G, Markesbery WR (2009) Organoselenium (Sel-Plex diet) decreases amyloid burden and RNA and DNA oxidative damage in APP/PS1 mice. Free Radic Biol Med 46, 1527-1533.
123. Tung Y, Hsu W, Wang B, Wu S, Yen C, Hu M, Liao Y (2008) Sodium selenite inhibits gamma-secretase activity through activation of ERK. Neurosci Lett 440, 38-43.
124. Valentine WM, Abel TW, Hill KE, Austin LM, Burk RF (2008) Neurodegeneration in mice resulting from loss of functional selenoprotein P or its receptor apolipoprotein E receptor 2. J Neuropathol Exp Neurol 67, 68-77.
125. Valentine WM, Hill KE, Austin LM, Valentine HL, Goldowitz D, Burk RF (2005) Brainstem axonal degeneration in mice with deletion of selenoprotein P. Toxicol Pathol 33, 570-576. (Pubitemid 41473092)
126. Yant LJ, Ran Q, Rao L, Van Remmen H, Shibatani T, Belter JG, Motta L, Richardson A, Prolla TA (2003) The selenopro-tein GPX4 is essential for mouse development and protects from radiation and oxidative damage insults.Free Radic Biol Med 34, 496-502. (Pubitemid 36140174)
127. Corcoran NM, Martin D, Hutter-Paier B, Windisch M, Nguyen T, Nheu L, Sundstrom LE, Costello AJ, Hovens CM (2010) Sodium selenate specifically activates PP2A phosphatase, dephosphorylates tau and reverses memory deficits in an Alzheimer's disease model. J Clin Neurosci 17, 1025-1033.
128. Pinton S, da Rocha JT, Zeni G, Nogueira CW (2010) Organoselenium improves memory decline in mice: involvement of acetylcholinesterase activity. Neurosci Lett 472, 56-60.
129. van Eersel J, Ke YD, Liu X, Delerue F, Kril JJ, Götz J, Ittner LM (2010) Sodium selenate mitigates tau pathology, neurodegeneration, and functional deficits in Alzheimer's disease models. Proc Natl Acad Sci USA 107, 13888-13893.
130. Binger KJ, Griffin MD, Heinemann SH, Howlett GJ (2010) Methionine-oxidized amyloid fibrils are poor substrates for human methionine sulfoxide reductases A and B2. Biochemistry 49, 2981-2983.
131. Misiti F, Clementi ME, Giardina B (2010) Oxidation of methionine 35 reduces toxicity of the amyloid beta-peptide (1-42) in neuroblastoma cells (IMR-32) via enzyme methionine sulfoxide reductase A expression and function. Neurochem Int 56, 597-602.
132. Ran Q, Gu M, Van Remmen H, Strong R, Roberts JL, Richardson A (2006) Glutathione peroxidase 4 protects cortical neurons from oxidative injury and amyloid toxicity. J Neurosci Res 84, 202-208. (Pubitemid 44023075)
133. Nishina A, Sekiguchi A, Fukumoto RH, Koketsu M, Furukawa S (2007) Selenazoles (selenium compounds) facilitate survival of cultured rat pheochromocytoma PC12 cells after serum-deprivation and stimulate their neuronal differentiation via activation of Akt and mitogen-activated protein kinase, respectively. Biochem Biophys Res Commun 352, 360-365. (Pubitemid 44838496)
134. El-Demerdash FM (2004) Antioxidant effect of vitamin E and selenium on lipid peroxidation, enzyme activities and biochemical parameters in rats exposed to aluminium. J Trace Elem Med Biol 18, 113-121. (Pubitemid 39285971)
135. Liu F, Grundke-Iqbal I, Iqbal K, Gong CX (2005) Contributions of protein phosphatases PP1, PP2A, PP2B and PP5 to the regulation of tau phosphorylation. Eur J Neurosci 22, 1942-1950. (Pubitemid 41579384)
136. Pal R, Oien DB, Ersen FY, Moskovitz J (2007) Elevated levels of brain-pathologies associated with neurodegenerative diseases in the methionine sulfoxide reductase A knockout mouse. Exp Brain Res 180, 765-774. (Pubitemid 46988121)
137. Crack PJ, Cimdins K, Ali U, Hertzog PJ, Iannello RC (2006) Lack of glutathione peroxidase-1 exacerbates Aβ-mediated neurotoxicity in cortical neurons. J Neural Transm 113, 645-657. (Pubitemid 43673604)
138. Hill KE, Zhou J, McMahan WJ, Motley AK, Burk RF (2004) Neurological dysfunction occurs in mice with targeted deletion of the selenoprotein P gene. J Nutr 134, 157-161. (Pubitemid 38057440)
139. Jung B, Lee EH, Chung WS, Lee SJ, Shin SH, Joo SH, Kim SK, Lee JH (2003) Increased viability of PC12 cells exposed to amyloid-beta peptide by transduction with human TAT-methionine sulfoxide reductase. Neuroreport 14, 2349-2353.
140. Tu HM, Legradi G, Bartha T, Salvatore D, Lechan RM, Larsen PR (1999) Regional expression of the type 3 iodothy-ronine deiodinase messenger ribonucleic acid in the rat central nervous system and its regulation by thyroid hormone. Endocrinology 140, 784-790. (Pubitemid 29058213)
141. Takemoto AS, Berry MJ, Bellinger FP (2010) Role of Selenoprotein P in Alzheimer's Disease. Ethn Dis 20, S1 92-95.
142. Gwon AR, Park JS, Park JH, Baik SH, Jeong HY, Hyun DH, Park KW, Jo DG (2010) Selenium attenuates A beta production and A beta-induced neuronal death. Neurosci Lett 469, 391-395.
143. Larabee JL, Hocker JR, Hanas JS (2009) Mechanisms of inhibition of zinc-finger transcription factors by selenium compounds ebselen and selenite. J Inorg Biochem 103, 419-426.
144. Xiong S, Markesbery WR, Shao C, Lovell MA (2007) Seleno-L-methionine protects against beta-amyloid and iron/hydrogen oeroxide-mediated neuron death. Antioxid Redox Signal 9, 457-467.
145. Kumar B, Nahreini P, Hanson AJ, Andreatta C, Prasad JE, Prasad KN (2005) Selenomethionine prevents degeneration induced by overexpression of wild-type human alpha-synuclein during differentiation of neuroblastoma cells. J Am Coll Nutr 24, 516-523. (Pubitemid 43373177)
146. Park YS, Misonou Y, Fujiwara N, Takahashi M, Miyamoto Y, Koh YH, Suzuki K, Taniguchi N (2005) Induction of thioredoxin reductase as an adaptive response to acrolein in human umbilical vein endothelial cells. Biochem Biophys Res Commun 327, 1058-1065. (Pubitemid 40137976)
147. Porciúncula LO, Rocha JB, Boeck CR, Vendite D, Souza DO (2001) Ebselen prevents excitotoxicity provoked by gluta-mate in rat cerebellar granule neurons. Neurosci Lett 299, 217-220. (Pubitemid 32124850)
148. Sasakura C, Suzuki KT (1998) Biological interaction between transition metals (Ag, Cd and Hg), selenide/sulfide and selenoprotein P. J Inorg Biochem 71, 159-162. (Pubitemid 28531535)
149. Penland JG (2006) Selenium status is associated with mood states and cognitive function in Chinese men. FASEB J 20, A1070.
150. Szaniszlo P, German P, Hajas G, Saenz DM, Woodberry MW, Kruzel ML, Boldogh I (2009) Effects of Colostrinin (TM) on gene expression-transcriptomal network analysis. Int Immunopharmacol 9, 181-193.
151. Bilikiewicz A, Gaus W (2004) Colostrinin (a naturally occurring, proline-rich, polypeptide mixture) in the treatment of Alzheimer's disease. J Alzheimers Dis 6, 17-26. (Pubitemid 38418554)
152. World Health Organization (1996) Trace Elements in Human Nutrition and Health, WHO, Geneva.
153. Kalmijn S, Launer LJ, Ott A, Witteman JC, Hofman A, Breteler MM (1997) Dietary fat intake and the risk of incident dementia in the Rotterdam Study. Ann Neurol 42, 776-782. (Pubitemid 27481550)
154. Huang TL, Zandi PP, Tucker KL, Fitzpatrick AL, Kuller LH, Fried LP, Burke
155. Barberger-Gateau P, Raffaitin C, Letenneur L, Berr C, Tzou-rio C, Dartigues JF, Alpérovitch A (2007) Dietary patterns and riskofdementia: the Three-City cohort study.Neurology 69, 1921-1930. (Pubitemid 350100350)
156. Longnecker MP, Stram DO, Taylor PR, Levander OA, Howe M, Veillon C, McAdam PA, Patterson KY, Holden JM, Morris JS, Swanson CA, Willett WC (1996) Use of selenium concentration in whole blood, serum, toenails, or urine as a surrogate measure of selenium intake. Epidemiology 7, 384-390. (Pubitemid 26202184)
157. Paglia DE, Valentine WN (1967) Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase. J Lab Clin Med 70, 158-169.
158. Woolliams JA, Wiener G, Anderson PH, McMurray CH (1983) Variation in the activities of glutathione peroxidase and superoxide dismutase and in the concentration of copper in the blood in various breed crosses of sheep. Res Vet Sci 34, 253-256. (Pubitemid 13070011)
159. Carmagnol F, Sinet PM, Jerome H (1983) Selenium-dependent and non-selenium-dependent glutathione perox-idases in human tissue extracts. Biochim Biophys Acta 759, 49-57. (Pubitemid 13013120)
160. Flohe L, Günzler WA (1984) Assays of glutathione peroxi-dase. Methods Enzymol 105, 114-121.
161. McCord JM, Fridovich I (1969) Superoxide dismutase. J Biol Chem 244, 6049-6055.
162. Gabbita SP, Aksenov MY, Lovell MA, Markesbery WR (1999) Decrease in peptide methionine sulfoxide reductase in Alzheimer's disease brain. J Neurochem 73, 1660-1666. (Pubitemid 29440169)
163. Ahmad AS, Ansari MA, Ahmad M, Saleem S, Yousuf S, Hoda MN, Islam F (2005) Neuroprotection by crocetin in a hemi-parkinsonian rat model. Pharmacol Biochem Behav 81, 805-813. (Pubitemid 41187813)
164. Grundman M, Delaney P (2009) Antioxidant strategies for Alzheimer's disease. Proc Nutr Soc 61, 191-202.
165. Halliwell B (2001) Role of free radicals in the neurode-generative diseases: therapeutic implications for antioxidant treatment. Drugs Aging 18, 685-716. (Pubitemid 32948277)
166. Halliwell B (1989) Oxidants and the central nervous system: some fundamental questions. Is oxidant damage relevant to Parkinson's disease, Alzheimer's disease, traumatic injury or stroke? Acta Neurol Scand 80, 23-33. (Pubitemid 20022073)
167. Williams TI, Lynn BC, Markesbery WR, Lovell MA (2006) Increased levels of 4-hydroxynonenal and acrolein, neuro-toxic markers of lipid peroxidation, in the brain in Mild Cognitive Impairment and early Alzheimer's disease. Neu-robiol Aging 27, 1094-1099. (Pubitemid 43850642)
168. Sayre LM, Zelasko DA, Harris PL, Perry G, Salomon RG, Smith MA (1997) 4-Hydroxynonenal-derived advanced lipid peroxidation end products are increasedin Alzheimer's disease. J Neurochem 68, 2092-2097. (Pubitemid 27176147)
169. Butterfield DA, Reed T, Perluigi M, De Marco C, Coccia R, Cini C, Sultana R (2006) Elevated protein-bound levels of the lipid peroxidation product, 4-hydroxy-2-nonenal, in brain from persons with mild cognitive impairment. Neu-rosci Lett 397, 170-173.
170. Zarkovic N (2003) 4-Hydroxynonenal as a bioactive marker of pathophysiological processes. Mol Aspects Med 24, 281-291. (Pubitemid 36945028)
171. Mark RJ, Lovell MA, Markesbery WR, Uchida K, Matt-son MP (1997) A role for 4-hydroxynonenal, an aldehydic product of lipid peroxidation, in disruption of ion home-ostasis and neuronal death inducedbyamyloid beta-peptide. J Neurochem 68, 255-264. (Pubitemid 26427315)
172. Montine KS, Kim PJ, Olson SJ, Markesbery WR, Montine TJ (1997) 4-Hydroxy-2-nonenal pyrrole adducts in human neurodegenerative disease. J Neuropathol Exp Neurol 56, 866-871. (Pubitemid 27329107)
173. Esler WP, Wolfe MS (2001) A portrait of Alzheimer sec-retases-new features and familiar faces. Science 293, 1449-1454. (Pubitemid 32801541)
174. Vassar R (2005) beta-Secretase, APP and Abeta in Alzheimer's disease. Subcell Biochem 38, 79-103.
175. Smith JL, Xiong S, Lovell MA (2006) 4-Hydroxynonenal disrupts zinc export in primary rat cortical cells. Neurotoxi-cology 27, 1-5. (Pubitemid 41745002)
176. Sensi SL, Paoletti P, Bush AI, Sekler I (2009) Zinc in the physiology and pathology of the CNS. Nat Rev Neurosci 10, 780-791.
177. Ramoutar RR, Brumaghim JL (2007) Effects of inorganic selenium compounds on oxidative DNA damage. J Inorg Biochem 101, 1028-1035. (Pubitemid 46899203)
178. Battin EE, Perron NR, Brumaghim JL (2006) The central role of metal coordination in selenium antioxidant activity. Inorg Chem 45, 499-501.
179. Battin EE, Brumaghim JL (2009) Antioxidant activity of sulfur and selenium: a review of reactive oxygen species scavenging, glutathione peroxidase, and metal-binding antioxidant mechanisms. Cell Biochem Biophys 55, 1-23.
180. Kosta L, Byrne AR, Zelenko V (1975) Correlation between selenium and mercury in man following exposure to inorganic mercury. Nature 254, 238-239.
181. Klotz LO, KrönckeKD, Buchczyk DP, Sies H (2003) Role of copper, zinc, selenium and tellurium in the cellular defense against oxidative and nitrosative stress. J Nutr 133, 1448S.
182. Brenneisen P, Steinbrenner H, Sies H (2005) Selenium, oxidative stress, and health aspects. Mol Aspects Med 26, 256-267. (Pubitemid 41225352)
183. Burk RF, Hill KE (2005) Selenoprotein P: an extracellular protein with unique physical characteristics and a role in selenium homeostasis. Annu Rev Nutr 25, 215-235. (Pubitemid 41209001)
184. Hoffmann PR, Höge SC, Li PA, Hoffmann FW, Hashimoto AC, Berry MJ (2007) The selenoproteome exhibits widely varying, tissue-specific dependence on selenoprotein P for selenium supply. Nucleic Acids Res 35, 3963-3973. (Pubitemid 47244618)
185. Steinbrenner H, Alili L, Bilgic E, Sies H, Brenneisen P (2006) Involvement of selenoprotein P in protection of human astrocytes from oxidative damage. Free Radical Biol Med 40, 1513-1523.
186. Lu T, Pan Y, Kao SY, Li C, Kohane I, Chan J, Yankner BA (2004) Gene regulation and DNA damage in the ageing human brain. Nature 429, 883-891. (Pubitemid 38843301)
187. Hill KE, Zhou J, Austin LM, Motley AK, Ham AJ, Olson GE, Atkins JF, Gesteland RF, Burk RF (2007) The selenium-rich C-terminal domain of mouse selenoprotein P is necessary for the supply of selenium to brain and testis but not for the maintenance of whole body selenium. J Biol Chem 282, 10972-10980. (Pubitemid 47100771)
188. Schomburg L, Schweizer U, Köhrle J (2004) Selenium and selenoproteins in mammals: extraordinary, essential, enigmatic. Cell Mol Life Sci 61, 1988-1995. (Pubitemid 39149889)
189. Korotkov KV, Novoselov SV, Hatfield DL, Gladyshev VN (2002) Mammalian selenoprotein in which selenocysteine (Sec) incorporation is supported by a new form of Sec insertion sequence element. Mol Cell Biol 22, 1402-1411. (Pubitemid 34150777)
190. Reeves MA, Bellinger FP, Berry MJ (2010) The neuropro-tective functions of selenoprotein M and its role in cytosolic calcium regulation. Antioxid Redox Signal 12, 812-818.
191. Beilstein MA, Vendeland SC, Barofsky E, Jensen ON, Whanger PD (1996) Selenoprotein W of rat muscle binds glutathione and an unknown small molecular weight moiety. J Inorg Biochem 61, 117-124. (Pubitemid 26049899)
192. Ben Jilani KE, Panee J, He Q, Berry MJ, Li PA (2007) Overexpression of selenoprotein H reduces Ht22 neuronal cell death after UVB irradiation by preventing superoxide formation. Int J Biol Sci 3, 198-204.
193. Jeong D, Kim TS, Chung YW, Lee BJ, Kim IY (2002) Selenoprotein W is a glutathione-dependent antioxidant in vivo. FEBS Lett 517, 225-228. (Pubitemid 34327664)
194. Morozova N, Forry EP, Shahid E, Zavacki AM, Harney JW, Kraytsberg Y, Berry MJ (2003) Antioxidant function of a novel selenoprotein in Drosophila melanogaster. Genes Cells 8, 963-971. (Pubitemid 38072272)
195. Lu C, Qiu F, Zhou H, Peng Y, Hao W, Xu J, Yuan J, Wang S, Qiang B, Xu C (2006) Identification and characterization of selenoprotein K: an antioxidant incardiomyocytes. FEBS Lett 580, 5189-5197. (Pubitemid 44430096)
196. Kim HY, Gladyshev VN (2007) Methionine sulfoxide reduc-tases: selenoprotein forms and roles in antioxidant protein repair in mammals. Biochem J 407, 321-329. (Pubitemid 350058466)
197. Moskovitz J, Berlett BS, Poston JM, Stadtman ER (1997) The yeast peptide-methionine sulfoxide reductase functions as an antioxidant in vivo. Proc Natl Acad Sci USA 94, 9585-9589. (Pubitemid 27408105)
198. Choi J, Sullards MC, Olzmann JA, Rees HD, Weintraub ST, Bostwick DE, Gearing M, Levey AI, Chin LS, Li L (2006) Oxidative damage of DJ-1 is linked to sporadic Parkinson and Alzheimer diseases. J Biol Chem 281, 10816-10824. (Pubitemid 43855504)
199. Hou L, Kang I, Marchant RE, Zagorski MG (2002) Methio-nine 35 oxidation reduces fibril assembly of the amyloid abeta-(1-42) peptide of Alzheimer's disease. J Biol Chem 277, 40173-40176. (Pubitemid 35215584)
200. Schöneich C (2005) Methionine oxidation by reactive oxygen species: reaction mechanisms and relevance to Alzheimer's disease. Biochim Biophys Acta 1703, 111-119. (Pubitemid 40170434)
201. Stadtman ER, Moskovitz J, Berlett BS, Levine RL (2002) Cyclic oxidation and reduction of protein methionine residues is an important antioxidant mechanism. Mol Cell Biochem 234, 3-9. (Pubitemid 34777836)
202. Moskovitz J, Stadtman ER (2003) Selenium-deficient diet enhances protein oxidation and affects methionine sulfoxide reductase (MsrB) protein levelincertain mouse tissues.Proc Natl Acad Sci USA 100, 7486-7490. (Pubitemid 36759996)
203. Varadarajan S, Kanski J, Aksenova M, Lauderback C, But-terfield DA (2001) Different mechanisms of oxidative stress and neurotoxicity for Alzheimer's abeta (1-42) and Abeta (25-35). J Am Chem Soc 123, 5625-5631. (Pubitemid 32904694)
204. Cheng WH, Ho YS, Valentine BA, Ross DA, Combs GF Jr, Lei XG (1998) Cellular glutathione peroxidase is the mediator of body selenium to protect against paraquat lethality in transgenic mice. J Nutr 128, 1070-1076. (Pubitemid 28317668)
205. Chen J, Berry MJ (2003) Selenium and selenoproteins in the brain and brain diseases. J Neurochem 86, 1-12. (Pubitemid 36753840)
206. Garcia T, Esparza JL, Nogués MR, Romeu M, Domingo JL, Gómez M (2010) Oxidative stress status and RNA expression in hippocampus of an animal model of Alzheimer's disease after chronic exposure to aluminum. Hippocampus 20, 218-225.
207. Somani SM, Husain K (1996) Exercise training alters kinetics of antioxidant enzymes in rat tissues. Biochem Mol Biol Int 38, 587-595. (Pubitemid 26258487)
208. Somani SM, Rybak LP (1996) Comparative effects of exercise training on transcription of antioxidant enzyme and the activity in old rat heart. Indian J Physiol Pharmacol 40, 205-212. (Pubitemid 26253745)
209. Turan B, Acan NL, Ulusu NN, Tezcan EF (2001) A comparative study on effect of dietary selenium and vitamin E on some antioxidant enzyme activitiesofliver and brain tissues. Biol Trace Elem Res 81, 141-152. (Pubitemid 32777776)
210. Chen K, Kazachkov M, Yu PH (2007) Effect of aldehydes derived from oxidative deamination and oxidative stress on beta-amyloid aggregation; pathological implications to Alzheimer's disease. J Neural Transm 114, 835-839. (Pubitemid 46980494)
211. Butterfield DA, Pocernich CB, Drake J (2002) Elevated glu-tathione as a therapeutic strategy in Alzheimer's disease. Drug Dev Res 56, 428-437. (Pubitemid 35168319)
212. Ballatori N, Krance SM, Notenboom S, Shi S, Tieu K, Hammond CL (2009) Glutathione dysregulation and the etiology and progression of human diseases. Biol Chem 390, 191-214.
213. Soerensen J, Jakupoglu C, Beck H, Förster H, Schmidt J, Schmahl W, Schweizer U, Conrad M, Brielmeier M (2008) The role of thioredoxin reductases in brain development. PLoS One 3, e1813.
214. Patenaude A, Murthy MR, Mirault ME (2005) Emerging roles of thioredoxin cycle enzymes in the central nervous system. Cell Mol Life Sci 62, 1063-1080. (Pubitemid 40868526)
215. Lovell MA, Xie C, Markesbery WR (2001) Acrolein is increased in Alzheimer's disease brain and is toxic to primary hippocampal cultures. Neurobiol Aging 22, 187-194. (Pubitemid 32162967)
216. Bosch-Morell F, Flohé L, Maŕin N, Romero FJ (1999) 4-Hydroxynonenal inhibits glutathione peroxidase: protection by glutathione. Free Radic Biol Med 26, 1383-1387. (Pubitemid 29302270)
217. Nikitovic D, Holmgren A (1996) S-nitrosoglutathione is cleaved by the thioredoxin system with liberation of glu-tathione and redox regulating nitric oxide. J Biol Chem 271, 19180-19185. (Pubitemid 26271582)
218. Akterin S, Cowburn RF, Miranda-Vizuete A, Jiménez A, Bogdanovic N, Winblad B, Cedazo-Minguez A (2006) Involvement of glutaredoxin-1 and thioredoxin-1 in beta-amyloid toxicity and Alzheimer's disease. Alzheimers Dement 2, S488.
219. Chen L, Na R, Gu M, Richardson A, Ran Q (2008) Lipid peroxidation up-regulates BACE1 expression in vivo: a possible early event of amyloidogenesis in Alzheimer's disease. J Neurochem 107, 197-207.
220. Kocherhans S, Madhusudan A, Doehner J, Breu KS, Nitsch RM, Fritschy JM, Knuesel I (2010) Reduced reelin expression accelerates Amyloid-beta plaque formation and tau pathology in transgenic Alzheimer's disease mice. J Neu-rosci 30, 9228-9240.
221. Grundke-Iqbal I, Iqbal K, Tung YC, Quinlan M, Wis-niewski HM, Binder LI (1986) Abnormal phosphorylation of the microtubule-associated protein tau (tau) in Alzheimer cytoskeletal pathology. Proc Natl Acad Sci USA 83, 4913-4917.
222. Brunden KR, Trojanowski JQ, Virginia VM (2009) Advances in tau-focused drug discovery for Alzheimer's disease and related tauopathies. Nat Rev Drug Discov 8, 783-793.
223. Avila J, Santa-Maria I, Perez M, Hernandez F, Moreno F (2006) Tau phosphorylation, aggregation, and cell toxicity. J Biomed Biotechnol 3, 74539.
224. Gong CX, Singh TJ, Grundke-Iqbal I, Iqbal K (1993) Phosphoprotein phosphatase activities in Alzheimer disease brain. J Neurochem 61, 921-927. (Pubitemid 23241228)
225. Sontag E, Luangpirom A, Hladik C, Mudrak I, Ogris E, Spe-ciale S, White CL 3rd (2004) Altered expression levels of the protein phosphatase 2A ABalpha C enzyme are associated with Alzheimer disease pathology. J Neuropathol Exp Neurol 63, 287-301. (Pubitemid 38429026)
226. Vogelsberg-Ragaglia V, Schuck T, Trojanowski JQ, Lee VM (2001) PP2A mRNA expression is quantitatively decreased in Alzheimer's disease hippocampus. Exp Neurol 168, 402-412. (Pubitemid 32289776)
227. Holmgren A (1985) Thioredoxin. Annu Rev Biochem 54, 237-271. (Pubitemid 15073647)
228. Aizenman E, Stout AK, Hartnett KA, Dineley KE, McLaughlin B, Reynolds IJ (2000) Induction of neuronal apoptosis by thiol oxidation. J Neurochem 75, 1878-1888.
229. Zatta P, Drago D, Bolognin S, Sensi SL (2009) Alzheimer's disease, metal ions and metal homeostatic therapy. Trends Pharmacol Sci 30, 346-355.
230. Schenk H, Klein M, Erdbrügger W, Dröge W, Schulze-Osthoff K (1994) Distinct effects of thioredoxin and antioxidants on the activation of transcription factors NF-kappa B and AP-1. Proc Natl Acad Sci USA 91, 1672-1676. (Pubitemid 24080267)
231. Anderson MT, Staal FJ, Gitler C, Herzenberg LA, Herzenberg LA (1994) Separation of oxidant-initiated and redox-regulated steps in the NF-kappa B signal transduction pathway. Proc Natl Acad Sci USA 91, 11527-11531. (Pubitemid 24356377)
232. Xanthoudakis S, Curran T (1992) Identification and characterization of Ref-1, a nuclear protein that facilitates AP-1 DNA-binding activity. EMBO J 11, 653-665.
233. Ueno M, Masutani H, Arai RJ, Yamauchi A, Hirota K, Sakai T, Inamoto T, Yamaoka Y, Yodoi J, Nikaido T (1999) Thioredoxin-dependent redox regulation of p53-mediated p21 activation. J Biol Chem 274, 35809-35815. (Pubitemid 129512885)
234. O'neill LA, Kaltschmidt C (1997) NF-kB: a crucial transcription factor for glial and neuronal cell function. Trends Neurosci 20, 252-258. (Pubitemid 27261456)
235. Barger SW, Mattson MP (1996) Induction of neuroprotec-tive kappa B-dependent transcription by secreted forms of the Alzheimer's beta-amyloid precursor. Mol Brain Res 40, 116-126. (Pubitemid 26241792)
236. Camandola S, Poli G, Mattson MP (2000) The lipid peroxi-dation product 4-hydroxy-2, 3-nonenal inhibits constitutive and inducible activity of nuclear factor kappa B in neurons. Mol Brain Res 85, 53-60. (Pubitemid 32056236)
237. Trejo J, Massamiri T, Deng T, Dewji NN, Bayney RM, Brown JH (1994) A direct role for protein kinase C and the transcription factor Jun/AP-1 in the regulation of the Alzheimer's beta-amyloid precursor protein gene. J Biol Chem 269, 21682-21690. (Pubitemid 24274808)
238. Kitamura Y, Shimohama S, Kamoshima W, Matsuoka Y, Nomura Y, Taniguchi T (1997) Changes of p53 in the brains of patients with Alzheimer's disease. Biochem Biophys Res Commun 232, 418-421. (Pubitemid 27216231)
239. Ohyagi Y, Asahara H, Chui D, Tsuruta Y, Sakae N, Miyoshi K, Yamada T, Kikuchi H, Taniwaki T, Murai H (2004) Intracellular Abeta42 activates p53 promoter: a pathway to neurodegeneration in Alzheimer's disease. FASEB J 19, 255-257. (Pubitemid 40189273)
240. Alves da Costa C, Sunyach C, Pardossi-Piquard R, Sevalle J, Vincent B, Boyer N, Kawarai T, Girardot N, St George-Hyslop P, Checler F (2006) Presenilin-dependent gamma-secretase-mediated control of p53-associated cell death in Alzheimer's disease. J Neurosci 26, 6377-6385.
241. Brasier A (2006) The NF-kB regulatory network. Cardio-vasc Toxicol 6, 111-130.
242. Schreck R, Albermann K, Baeuerle PA (1992) Nuclear factor kappa B: an oxidative stress-responsive transcription factor of eukaryotic cells (a review). Free Radic Res 17, 221-237. (Pubitemid 23207431)
243. Vunta H, Belda BJ, Arner RJ, Channa Reddy C, Vanden Heuvel JP, Sandeep Prabhu K (2008) Selenium attenuates pro-inflammatory gene expression in macrophages. Mol Nutr Food Res 52, 1316-1323.
244. Makropoulos V, Brüning T, Schulze-Osthoff K (1996) Selenium-mediated inhibition of transcription factor NF-kappa B and HIV-1 LTR promoter activity. Arch Toxicol 70, 277-283.
245. Brigelius-Flohe R, Friedrichs B, Maurer S, Schultz M, Streicher R (1997) Interleukin-1-induced nuclear factor kappa B activation is inhibited by overexpression of phos-pholipid hydroperoxide glutathione peroxidase in a human endothelial cell line. Biochem J 328, 199-203. (Pubitemid 27499459)
246. Morey M, Serras F, Baguñá J, Hafen E, Corominas M (2001) Modulation of the Ras/MAPK signalling pathway by the redox function of selenoproteins in Drosophila melanogaster. Dev Biol 238, 145-156. (Pubitemid 32939292)
247. Squires JE, Davy P, Berry MJ, Allsopp R (2009) Attenuated expression of SECIS binding protein 2 causes loss of telom-eric reserve without affecting telomerase. Exp Gerontol 44, 619-623.
248. Liu Q, Wang H, Hu D, Ding C, Xu H, Tao D (2004) Effects of trace elements on the telomere lengths of hepatocytes L-02 and hepatoma cells SMMC-7721. Biol Trace Elem Res 100, 215-227. (Pubitemid 39390050)
249. Cui QH, Tang CC, Huang YG (2002) Effects of lead and selenium on telomere binding protein Rap1 p, telomerase and telomeric DNA in Saccharomyces cerevisiae. Acta Biochim Biophys Sin 34, 240-244.
250. Honig LS, Schupf N, Lee JH, Tang MX, Mayeux R (2006) Shorter telomeres are associated with mortality in those with APOE epsilon4 and dementia. Ann Neurol 60, 181-187. (Pubitemid 44182393)
251. Thomas P, O'Callaghan NJ, Fenech M (2008) Telomere length in white blood cells, buccal cells and brain tissue and its variation with ageing and Alzheimer's disease. Mech Ageing Dev 129, 183-190.
252. Oulhaj A, Refsum H, Beaumont H, Williams J, King E, Jacoby R, Smith AD (2010) Homocysteine as a predictor of cognitive decline in Alzheimer's disease. Int J Geriatr Psychiatry 25, 82-90.
253. Seshadri S, Beiser A, Selhub J, Jacques P, Rosenberg I, D'Agostino R, Wilson P, Wolf P (2002) Plasma homocys-teine as a risk factor for dementia and Alzheimer's disease. New Engl J Med 346, 476-483. (Pubitemid 34441738)
254. Kruman II, Kumaravel TS, Lohani A, Pedersen WA, Cutler RG, Kruman Y, Haughey N, Lee J, Evans M, Mattson MP (2002) Folic acid deficiency and homocysteine impair DNArepair in hippocampal neurons and sensitize them to amyloid toxicity in experimental models ofAlzheimer's disease. J Neurosci 22, 1752-1762. (Pubitemid 35386293)
255. Seshadri S (2006) Elevated plasma homocysteine levels: risk factor or risk marker for the development of dementia and Alzheimer's disease? J Alzheimers Dis 9, 393-398.
256. Selhub J (1999) Homocysteine metabolism. Annu Rev Nutr 19, 217-246. (Pubitemid 29380603)
257. Ho PI, Ortiz D, Rogers E, Shea TB (2002) Multiple aspects of homocysteine neurotoxicity: glutamate excitotoxicity, kinase hyperactivation and DNA damage. J Neurosci Res 70, 694-702. (Pubitemid 35397143)
258. Xu D, Neville R, Finkel T (2000) Homocysteine accelerates endothelial cell senescence. FEBS Lett 470, 20-24. (Pubitemid 30155616)
259. Vafai SB, Stock JB (2002) Protein phosphatase 2A methy-lation: a link between elevated plasma homocysteine and Alzheimer's disease. FEBS Lett 518, 1-4. (Pubitemid 34454953)
260. Sai X, Kawamura Y, Kokame K, Yamaguchi H, Shiraishi H, Suzuki R, Suzuki T, Kawaichi M, Miyata T, Kitamura T (2002) Endoplasmic reticulum stress-inducible protein, Herp, enhances presenilin-mediated generation of amyloid beta-protein. J Biol Chem 277, 12915-12920. (Pubitemid 34952658)
261. Sontag E, Nunbhakdi-Craig V, Sontag JM, Diaz-Arrastia R, Ogris E, Dayal S, Lentz SR, Arning E, Bottiglieri T (2007) Protein phosphatase 2A methyltransferase links homocys-teine metabolism with tau and amyloid precursor protein regulation. J Neurosci 27, 2751-2759. (Pubitemid 46438990)
262. Gonzalez S, Huerta J, Alvarez-Uria J, Fernandez S, Patter-sonA, Lasheras C (2004) Serum selenium is associated with plasma homocysteine concentrations in elderly humans. J Nutr 134, 1736-1740. (Pubitemid 38886562)
263. Lai MK, Ramirez MJ, Tsang SW, Francis PT (2007) Alzheimer's Disease as a neurotransmitter disease. In Neu-robiology of Alzheimer's Disease, Dawbarn D, Shelley A, eds. Oxford University Press, New York, pp. 245-283.
264. Terry AV Jr, Buccafusco JJ (2003) The cholinergic hypothesis ofage and Alzheimer's disease-related cognitive deficits: recent challenges and their implications for novel drug development. J Pharmacol Exp Ther 306, 821-827. (Pubitemid 37025286)
265. Birks J, Grimley Evans J, Iakovidou V, Tsolaki M, Holt FE (2009) Rivastigmine for Alzheimer's disease. Cochrane Database Sys Rev 15, CD001191.
266. Tillement JP, Lecanu L, Papadopoulos V (2009) Amyloi-dosis and neurodegenerative diseases: current treatments and new pharmacological options. Pharmacology 85, 1-17.
267. LaFerla FM (2002) Calcium dyshomeostasis and intracel-lular signalling in Alzheimer's disease. Nat Rev Neurosci 3, 862-872.
268. Peters MM, Hill KE, Burk RF, Weeber EJ (2006) Altered hippocampus synaptic function in selenoprotein P deficient mice. Mol Neurodegener 1, 12.
269. Nogueira CW, Rotta LN, Perry ML, Souza DO, da Rocha JB (2001) Diphenyl diselenide and diphenyl ditelluride affect the rat glutamatergic system in vitro and in vivo. Brain Res 906, 157-163. (Pubitemid 32595550)
270. Mutter J, Curth A, Naumann R, Deth R, Walach H (2010) Does inorganic mercury play a role in Alzheimer's disease? A systematic review and an integrated molecular mechanism. J Alzheimers Dis 22, 357-374.
271. Berry MJ, Ralston NV (2008) Mercury toxicity and the mitigating role of selenium. Eco Health 5, 456-459.
272. Yang DY, Chen YW, Gunn JM, Belzile N (2008) Selenium and mercury in organisms: interactions and mechanisms. Environ Rev 16, 71-92.
273. Raymond LJ, Ralston NV (2004) Mercury: selenium interactions and health implications. Seychelles Med Dent J 7, 72-77.
274. Dyrssen D, Wedborg M (1991) The sulphur-mercury (II) system in natural waters. Water Air Soil Pollut 56, 507-519.
275. Nuttall KL (2006) Evaluating selenium poisoning. Ann Clin Lab Sci 36, 409-420. (Pubitemid 44786687)
276. Pendergrass JC, Haley BE, Vimy MJ, Winfield SA, Lorscheider FL (1997) Mercury vapor inhalation inhibits binding of GTP to tubulin rat brain: similarity to a molecular lesion in Alzheimer diseases brain. Neurotoxicology 18, 315-324. (Pubitemid 27392641)
277. Olivieri G, Brack C, Müller-Spahn F, Stähelin HB, Herrmann M, Renard P, Brockhaus M, Hock C (2000) Mercury induces cell cytotoxicity and oxidative stress and increases-amyloid secretion and tau phosphorylation in SHSY5Y neuroblastoma cells. J Neurochem 74, 231-236. (Pubitemid 30012773)
278. Olivieri G, Novakovic M, Savaskan E, Meier F, Baysang G, Brockhaus M, Müller-Spahn F (2002) The effects of beta-estradiol on SHSY5Y neuroblastoma cells during heavy metal induced oxidative stress, neurotoxicity and beta-amyloid secretion. Neuroscience 113, 849-855. (Pubitemid 35245254)
279. Ralston NV, Ralston CR, Blackwell JL 3 rd, Raymond LJ (2008) Dietary and tissue selenium in relation to methylmer-cury toxicity. Neurotoxicology 29, 802-811.
280. Drasch G, Mailänder S, Schlosser C, Roider G (2000) Content of non-mercury-associated selenium in human tissues. Biol Trace Elem Res 77, 219-230. (Pubitemid 32060711)
281. Fung YK, Meade AG, Rack EP, Blotcky AJ, Claassen JP, Beatty MW, Durham T (1995) Determination of blood mercury concentrations in Alzheimer's patients. Clin Toxicol 33, 243-247.
282. Redhe O, Pleva J (1993) Recovery from amyotrophic lateral sclerosis and from allergy after removal of dental amalgam fillings. Int J Risk Saf Med 4, 229-236. (Pubitemid 24026227)
283. Frisardi V, Solfrizzi V, Capurso C, Kehoe P, Imbimbo B, Santamato A, Dellegrazie F, Seripa D, Pilotto A, Capurso A (2010) Aluminum in the diet and Alzheimer's disease: from current epidemiology to possible disease-modifying treatment. J Alzheimers Dis 20, 17-30.
284. Ashton K, Hooper L, Harvey LJ, Hurst R, Casgrain A, Fairweather-Tait SJ (2009) Methods of assessment of selenium status in humans: a systematic review. Am J Clin Nutr 89, 2025S-2039S.
285. Richardson DR (2005) More roles for selenoprotein P: local selenium storage and recycling protein inthe brain.Biochem J 386, e5-e7.
286. Schomburg L, Schweizer U (2009) Hierarchical regulation of selenoprotein expression and sex-specific effects of selenium. Biochim Biophys Acta 1790, 1453-1462.
287. Schweizer U, Bräuer AU, Köhrle J, Nitsch R, Savaskan NE (2004) Selenium and brain function: a poorly recognized liaison. Brain Res Rev 45, 164-178. (Pubitemid 38802869)
288. Larsen NA, Pakkenberg H, Damsgaard E, Heydorn K (1979) Topographical distribution of arsenic, manganese, and selenium in the normal human brain. J Neurol Sci 42, 407-416. (Pubitemid 9188019)
289. Gao HL, Zheng W, Xin N, Chi ZH, Wang ZY, Chen J, Wang ZY (2009) Zinc deficiency reduces neurogenesis accompanied by neuronal apoptosis through caspase-dependent and-independent signaling pathways.Neurotox Res 16, 416-425.
290. Brown KH, Wuehler SE, Peerson JM (2001) The importance of zinc in human nutrition and estimation of the global prevalence of zinc deficiency. Food Nutr Bull 22, 113-125. (Pubitemid 32653119)
291. Olivieri O, Stanzial AM, Girelli D, Trevisan MT, Guarini P, Terzi M, Caffi S, Fontana F, Casaril M, Ferrari S, et al. (1994) Selenium status, fatty acids, vitamins A and E, and aging: the Nove Study. Am J Clin Nutr 60, 510-517.
292. Hoekstra W (1975) Biochemical function of selenium and its relation to vitamin E. Fed Broc 11, 2083-2089.
293. Schrauzer GN (2003) The nutritional significance, metabolism and toxicology of selenomethionine. Adv Food Nutr Res 47, 73-112. (Pubitemid 137640845)
294. Turchan J, Pocernich CB, Gairola C, Chauhan A, Schifitto G, Butterfield DA, Buch S, Narayan O, Sinai A, Geiger J, Berger JR, Elford H, Nath A (2003) Oxidative stress in HIV demented patients and protection ex vivo with novel antioxidants. Neurology 60, 307-314. (Pubitemid 36152028)
295. Steiner J, Haughey N, Li W, Venkatesan A, Anderson C, Reid R, Malpica T, Pocernich C, Butterfield DA, Nath A (2006) Oxidative stress and therapeutic approaches in HIV dementia. Antioxid Redox Signal 8, 2089-2100. (Pubitemid 46489633)
296. Levander OA (1987) A global view of human selenium nutrition. Annu Rev Nutr 7, 227-250.
297. Combs GF Jr (2001) Selenium in global food systems. Br J Nutr 85, 517-547. (Pubitemid 32479141)
298. Schrauzer GN (2000) Selenomethionine: a review of its nutritional significance, metabolismand toxicity.J Nutr130, 1653-1656. (Pubitemid 30451048)
299. Choi YB, Lipton SA (2000) Redox modulation of the NMDA receptor. Cell Mol Life Sci 57, 1535-1541.